cisapride has been researched along with Helicobacter Infections in 18 studies
Cisapride: A substituted benzamide used for its prokinetic properties. It is used in the management of gastroesophageal reflux disease, functional dyspepsia, and other disorders associated with impaired gastrointestinal motility. (Martindale The Extra Pharmacopoeia, 31st ed)
cisapride : The amide resulting from formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with cis-1-[3-(4-fluorophenoxy)propyl]-3-methoxypiperidin-4-amine. It has been used (as its monohydrate or as its tartrate) for the treatment of gastro-oesophageal reflux disease and for non-ulcer dyspepsia, but its propensity to cause cardiac arrhythmias resulted in its complete withdrawal from many countries, including the U.K., and restrictions on its use elsewhere.
Helicobacter Infections: Infections with organisms of the genus HELICOBACTER, particularly, in humans, HELICOBACTER PYLORI. The clinical manifestations are focused in the stomach, usually the gastric mucosa and antrum, and the upper duodenum. This infection plays a major role in the pathogenesis of type B gastritis and peptic ulcer disease.
| Excerpt | Relevance | Reference |
|---|---|---|
| " pylori infection has an effect on the improvement of dyspeptic symptoms in response to a prokinetic agent, cisapride, in patients with non-ulcer dyspepsia (NUD)." | 9.11 | Lack of effect of Helicobacter pylori on symptom improvement with a prokinetic medication, cisapride, in patients with non-ulcer dyspepsia. ( Chaiwatanarat, T; Gonlachanvit, S; Kullavanijaya, P; Mahachai, V, 2005) |
| "To compare the efficacy of simethicone with placebo and the prokinetic cisapride in patients with functional dyspepsia." | 9.10 | A randomized placebo-controlled trial of simethicone and cisapride for the treatment of patients with functional dyspepsia. ( Gschossmann, J; Holtmann, G; Mayr, P; Talley, NJ, 2002) |
| "The aim of this study was to compare symptoms for patients with uninvestigated dyspepsia and a negative Helicobacter pylori serology who were treated with cisapride or placebo." | 9.09 | Treatment of uninvestigated dyspepsia with cisapride for patients with negative Helicobacter pylori serologies. ( Avins, AL; Kearney, DJ; McQuaid, KR, 2000) |
| "Functional dyspepsia is recognized as a common disorder in clinical practice." | 6.68 | Cisapride in functional dyspepsia in general practice. A placebo-controlled, randomized, double-blind study. ( de Both, PS; de Groot, GH, 1997) |
| " pylori infection has an effect on the improvement of dyspeptic symptoms in response to a prokinetic agent, cisapride, in patients with non-ulcer dyspepsia (NUD)." | 5.11 | Lack of effect of Helicobacter pylori on symptom improvement with a prokinetic medication, cisapride, in patients with non-ulcer dyspepsia. ( Chaiwatanarat, T; Gonlachanvit, S; Kullavanijaya, P; Mahachai, V, 2005) |
| "To compare the efficacy of simethicone with placebo and the prokinetic cisapride in patients with functional dyspepsia." | 5.10 | A randomized placebo-controlled trial of simethicone and cisapride for the treatment of patients with functional dyspepsia. ( Gschossmann, J; Holtmann, G; Mayr, P; Talley, NJ, 2002) |
| "The aim of this study was to compare symptoms for patients with uninvestigated dyspepsia and a negative Helicobacter pylori serology who were treated with cisapride or placebo." | 5.09 | Treatment of uninvestigated dyspepsia with cisapride for patients with negative Helicobacter pylori serologies. ( Avins, AL; Kearney, DJ; McQuaid, KR, 2000) |
| "Functional dyspepsia is recognized as a common disorder in clinical practice." | 2.68 | Cisapride in functional dyspepsia in general practice. A placebo-controlled, randomized, double-blind study. ( de Both, PS; de Groot, GH, 1997) |
| "Non-ulcer dyspepsia is common and is often confused with other diagnoses." | 2.42 | Update on the role of drug therapy in non-ulcer dyspepsia. ( Talley, NJ, 2003) |
| "Dyspepsia is most optimally defined as pain or discomfort centred in the upper abdomen." | 2.40 | Management guidelines for uninvestigated and functional dyspepsia in the Asia-Pacific region: First Asian Pacific Working Party on Functional Dyspepsia. ( Fock, KM; Goh, KL; Lam, SK; Talley, NJ, 1998) |
| "Dyspepsia affects one in four Australians; of those who present in general practice, the majority will have functional or non-ulcer dyspepsia, with no structural explanation for their symptoms." | 2.39 | Modern management of dyspepsia. ( Talley, NJ, 1996) |
| "Functional dyspepsia is one of the most common functional disorders of the gastrointestinal tract, which resulted from impaired motor skills, visceral hypersensitivity, increased mucosal permeability, disorders of the autonomic nervous system, etc." | 1.62 | [Rational treatment of patients with functional dyspepsia]. ( Kazakov, AS; Nasretdinova, EK; Ushkalova, EA; Zyryanov, SK, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (44.44) | 18.2507 |
| 2000's | 9 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (5.56) | 2.80 |
| Authors | Studies |
|---|---|
| Kazakov, AS | 1 |
| Zyryanov, SK | 1 |
| Ushkalova, EA | 1 |
| Nasretdinova, EK | 1 |
| Holtmann, G | 2 |
| Gschossmann, J | 1 |
| Mayr, P | 1 |
| Talley, NJ | 5 |
| Buzás, GM | 1 |
| Gonlachanvit, S | 1 |
| Mahachai, V | 1 |
| Chaiwatanarat, T | 1 |
| Kullavanijaya, P | 1 |
| Ang, TL | 1 |
| Fock, KM | 2 |
| Teo, EK | 1 |
| Chan, YH | 1 |
| Ng, TM | 1 |
| Chua, TS | 1 |
| Tan, JY | 1 |
| Frazzoni, M | 1 |
| Lonardo, A | 1 |
| Grisendi, A | 1 |
| Della Casa, G | 1 |
| Pulvirenti, M | 1 |
| Ferrari, AM | 1 |
| Di Gregorio, C | 1 |
| Melini, L | 1 |
| Hudziak, H | 1 |
| de Groot, GH | 1 |
| de Both, PS | 1 |
| Lam, SK | 1 |
| Goh, KL | 1 |
| Chassany, O | 1 |
| Douet, MC | 1 |
| Ducrot, F | 1 |
| Kearney, DJ | 1 |
| Avins, AL | 1 |
| McQuaid, KR | 1 |
| Radwan, P | 1 |
| Grodzieński, R | 1 |
| Zaorska-Rajca, J | 1 |
| Skrzydło-Radomańska, B | 1 |
| Słomka, M | 1 |
| Wysokiński, A | 1 |
| Hansen, JM | 1 |
| Bytzer, P | 1 |
| Spiroglou, K | 1 |
| Chatziparasidis, G | 1 |
| Paroutoglou, G | 1 |
| Demertzidou, V | 1 |
| Giouleme, O | 1 |
| Nikolaides, N | 1 |
| Evgenides, N | 1 |
6 reviews available for cisapride and Helicobacter Infections
| Article | Year |
|---|---|
Update on the role of drug therapy in non-ulcer dyspepsia.
Topics: Anti-Ulcer Agents; Antidepressive Agents, Tricyclic; Cisapride; Dopamine Antagonists; Dyspepsia; Gas | 2003 |
Functional dyspepsia. Current treatment recommendations.
Topics: Cisapride; Dopamine Antagonists; Dyspepsia; Gastric Acid; Gastrointestinal Agents; Gastrointestinal | 1993 |
Modern management of dyspepsia.
Topics: Adult; Aged; Antacids; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Bismuth; Child; C | 1996 |
[Treatment of stomach ulcer].
Topics: Anti-Ulcer Agents; Cisapride; Drug Resistance; Helicobacter Infections; Histamine H2 Antagonists; Hu | 1996 |
Management guidelines for uninvestigated and functional dyspepsia in the Asia-Pacific region: First Asian Pacific Working Party on Functional Dyspepsia.
Topics: Antiemetics; Asia; Cisapride; Disease Management; Domperidone; Dyspepsia; Endoscopy; Gastrointestina | 1998 |
[Gastroesophageal reflux in adults: diagnosis and treatment. Conclusions of Consensus Conference: long text. Organized by the French National Society of Gastroenterology and Belgian Royal Society of Gastroenterology/Flemish Society of Gastroenterology. Fr
Topics: Adult; Age Factors; Antacids; Anti-Ulcer Agents; Cisapride; Clinical Trials as Topic; Diagnosis, Dif | 1999 |
7 trials available for cisapride and Helicobacter Infections
| Article | Year |
|---|---|
A randomized placebo-controlled trial of simethicone and cisapride for the treatment of patients with functional dyspepsia.
Topics: Adult; Aged; Cisapride; Double-Blind Method; Dyspepsia; Female; Gastrointestinal Agents; Health Stat | 2002 |
Lack of effect of Helicobacter pylori on symptom improvement with a prokinetic medication, cisapride, in patients with non-ulcer dyspepsia.
Topics: Adult; Cholinergic Agonists; Cisapride; Drug Administration Schedule; Dyspepsia; Female; Gastric Emp | 2005 |
Helicobacter pylori eradication versus prokinetics in the treatment of functional dyspepsia: a randomized, double-blind study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Infective Agents; Cisapride; Clari | 2006 |
Are routine duodenal and antral biopsies useful in the management of "functional" dyspepsia? A diagnostic and therapeutic study.
Topics: Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Bismuth; Cisapride; Double-Blind Method; Du | 1993 |
Cisapride in functional dyspepsia in general practice. A placebo-controlled, randomized, double-blind study.
Topics: Adolescent; Adult; Aged; Anti-Ulcer Agents; Cisapride; Diagnosis, Differential; Double-Blind Method; | 1997 |
Treatment of uninvestigated dyspepsia with cisapride for patients with negative Helicobacter pylori serologies.
Topics: Administration, Oral; Adult; Antibodies, Bacterial; Cisapride; Diagnosis, Differential; Dyspepsia; F | 2000 |
[The effect of prokinetic treatment and eradication of Helicobacter pylori on gastric emptying and symptoms of functional dyspepsia].
Topics: Adolescent; Adult; Cisapride; Drug Therapy, Combination; Dyspepsia; Famotidine; Female; Gastric Empt | 2001 |
5 other studies available for cisapride and Helicobacter Infections
| Article | Year |
|---|---|
[Rational treatment of patients with functional dyspepsia].
Topics: Antidepressive Agents, Tricyclic; Cisapride; Domperidone; Dyspepsia; Helicobacter Infections; Humans | 2021 |
[The effect of Helicobacter pylori eradication on prokinetic treatment on the quality of life in functional dyspepsia].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Benzimidazoles | 2004 |
[What are the results of medical treatments?].
Topics: Antacids; Cisapride; Gastroesophageal Reflux; Gastrointestinal Agents; Helicobacter Infections; Heli | 1999 |
[Drug therapy of functional dyspepsia. A review based on Cochrane Reviews].
Topics: Antacids; Cisapride; Databases, Bibliographic; Dyspepsia; Evidence-Based Medicine; Gastrointestinal | 2001 |
Functional dyspepsia in children.
Topics: Adolescent; Anti-Ulcer Agents; Child; Child, Preschool; Cisapride; Diagnosis, Differential; Dyspepsi | 2001 |